Browse Arkansas Code titles and sections
18 U.S.C. § 220 — Illegal remunerations for referrals to re-
Federal law — U.S. Code and appendices · legal_authorities
Page 84
TITLE 18—CRIMES AND CRIMINAL PROCEDURE
§ 219
tion 218 of title 18 of the United States Code in relation
to which there has been a final conviction for any vio-
lation of chapter 11 of title 18.
SEC. 2. The head of each Executive department and
agency described in section 1 may exercise the author-
ity hereby delegated by promulgating implementing
regulations; provided that the Secretary of Defense, the
Administrator of General Services and the Adminis-
trator of the National Aeronautics and Space Adminis-
tration jointly shall issue government-wide imple-
menting regulations related to voiding or rescission of
contracts.
SEC. 3. Implementing regulations adopted pursuant to
this Order shall, at a minimum, provide the following
procedural protections:
(a) Written notice of the proposed action shall be
given in each case to the person or entity affected;
(b) The person or entity affected shall be afforded an
opportunity to submit pertinent information on its be-
half before a final decision is made;
(c) Upon the request of the person or entity affected,
a hearing shall be held at which it shall have the oppor-
tunity to call witnesses on its behalf and confront any
witness the agency may present; and
(d) The head of the agency or his designee shall issue
a final written decision specifying the amount of res-
titution or any other remedy authorized by section 218,
provided that such remedy shall take into consider-
ation the fair value of any tangible benefits received
and retained by the agency.
RONALD REAGAN.
§ 219. Officers and employees acting as agents of
foreign principals
(a) Whoever, being a public official, is or acts
as an agent of a foreign principal required to
register under the Foreign Agents Registration
Act of 1938 or a lob
Source: Supplied 2024 U.S. Code historical extraction · 18 U.S.C. § 220
Stored review status: historical_2024_not_currentness_verified. A text match is a research starting point; applicability is not established.
Original supplied file — preserved unchanged
Download original Markdown file
File SHA-256: 8233b0c74f2a7c5a3fa1696dedcd02520df0d4a3465fb21272667831a356943b. The original may include catalog metadata, neighboring provisions, or embedded records outside this collection's scope. Search shows only the selected federal record. Historical editions and unverified snapshots are not a statement of current law.
Authority boundary: historical or unconfirmed source not current law verified.
Open the recorded source website ↗
Record provenance
Stable record: federal_law:legal_authorities:usc2024-6911c62c51b9975390a3041b
Source file: Laws/federal/codes/united-states-code-2024/title-18/section-220-illegal-remunerations-for-referrals-to-re--661a5bba18.md
Pages: Not recorded – Not recorded
Passage SHA-256: 9644e4f40753ddecc2f58a3210debb66c380f08f31fdee71db4f27356795121b
Source location: USCODE-2024-title18-partI-chap11-sec220.pdf
Stored source content
Page 84
TITLE 18—CRIMES AND CRIMINAL PROCEDURE
§ 219
tion 218 of title 18 of the United States Code in relation
to which there has been a final conviction for any vio-
lation of chapter 11 of title 18.
SEC. 2. The head of each Executive department and
agency described in section 1 may exercise the author-
ity hereby delegated by promulgating implementing
regulations; provided that the Secretary of Defense, the
Administrator of General Services and the Adminis-
trator of the National Aeronautics and Space Adminis-
tration jointly shall issue government-wide imple-
menting regulations related to voiding or rescission of
contracts.
SEC. 3. Implementing regulations adopted pursuant to
this Order shall, at a minimum, provide the following
procedural protections:
(a) Written notice of the proposed action shall be
given in each case to the person or entity affected;
(b) The person or entity affected shall be afforded an
opportunity to submit pertinent information on its be-
half before a final decision is made;
(c) Upon the request of the person or entity affected,
a hearing shall be held at which it shall have the oppor-
tunity to call witnesses on its behalf and confront any
witness the agency may present; and
(d) The head of the agency or his designee shall issue
a final written decision specifying the amount of res-
titution or any other remedy authorized by section 218,
provided that such remedy shall take into consider-
ation the fair value of any tangible benefits received
and retained by the agency.
RONALD REAGAN.
§ 219. Officers and employees acting as agents of
foreign principals
(a) Whoever, being a public official, is or acts
as an agent of a foreign principal required to
register under the Foreign Agents Registration
Act of 1938 or a lobbyist required to register
under the Lobbying Disclosure Act of 1995 in
connection with the representation of a foreign
entity, as defined in section 3(6) of that Act
shall be fined under this title or imprisoned for
not more than two years, or both.
(b) Nothing in this section shall apply to the
employment of any agent of a foreign principal
as a special Government employee in any case in
which the head of the employing agency cer-
tifies that such employment is required in the
national interest. A copy of any certification
under this paragraph shall be forwarded by the
head of such agency to the Attorney General
who shall cause the same to be filed with the
registration statement and other documents
filed by such agent, and made available for pub-
lic inspection in accordance with section 6 of the
Foreign Agents Registration Act of 1938, as
amended.
(c) For the purpose of this section ‘‘public offi-
cial’’ means Member of Congress, Delegate, or
Resident Commissioner, either before or after he
has qualified, or an officer or employee or per-
son acting for or on behalf of the United States,
or any department, agency, or branch of Govern-
ment thereof, including the District of Colum-
bia, in any official function, under or by author-
ity of any such department, agency, or branch of
Government.
(Added Pub. L. 89–486, § 8(b), July 4, 1966, 80 Stat.
249; amended Pub. L. 98–473, title II, § 1116, Oct.
12, 1984, 98 Stat. 2149; Pub. L. 99–646, § 30, Nov. 10,
1986, 100 Stat. 3598; Pub. L. 101–647, title XXXV,
§ 3511, Nov. 29, 1990, 104 Stat. 4922; Pub. L. 104–65,
§ 12(b), Dec. 19, 1995, 109 Stat. 701.)
Editorial Notes
REFERENCES IN TEXT
The Foreign Agents Registration Act of 1938, as
amended, referred to in subsec. (a), is act June 8, 1938,
ch. 327, 52 Stat. 631, which is classified generally to sub-
chapter II (§ 611 et seq.) of chapter 11 of Title 22, For-
eign Relations and Intercourse. Section 6 of the For-
eign Agents Registration Act of 1938 is classified to sec-
tion 616 of Title 22. For complete classification of this
Act to the Code, see Short Title note set out under sec-
tion 611 of Title 22 and Tables.
The Lobbying Disclosure Act of 1995, referred to in
subsec. (a), is Pub. L. 104–65, Dec. 19, 1995, 109 Stat. 691,
which is classified principally to chapter 26 (§ 1601 et
seq.) of Title 2, The Congress. Section 3(6) of the Act is
classified to section 1602(6) of Title 2. For complete
classification of this Act to the Code, see Short Title
note set out under section 1601 of Title 2 and Tables.
PRIOR PROVISIONS
A prior section 219 was renumbered section 214.
AMENDMENTS
1995—Subsec. (a). Pub. L. 104–65 substituted ‘‘or a lob-
byist required to register under the Lobbying Disclo-
sure Act of 1995 in connection with the representation
of a foreign entity, as defined in section 3(6) of that
Act’’ for ‘‘, as amended,’’.
1990—Subsec. (c). Pub. L. 101–647 substituted ‘‘Govern-
ment’’ for ‘‘Governments’’ before ‘‘thereof’’.
1986—Subsec. (a). Pub. L. 99–646, § 30(1), designated
first par. as subsec. (a) and amended it generally, which
prior to amendment read as follows: ‘‘Whoever, being a
public official of the United States in the executive,
legislative, or judicial branch of the Government or in
any agency of the United States, including the District
of Columbia, is or acts as an agent of a foreign prin-
cipal required to register under the Foreign Agents
Registration Act of 1938, as amended, shall be fined not
more than $10,000 or imprisoned for not more than two
years, or both.’’
Subsec. (b). Pub. L. 99–646, § 30(2), designated second
par. as subsec. (b).
Subsec. (c). Pub. L. 99–646, § 30(2), (3), designated third
par. as subsec. (c) and substituted ‘‘Delegate’’ for ‘‘Del-
egate from the District of Columbia’’ and ‘‘branch of
Government’’ for ‘‘branch of Government, or a juror’’.
1984—Pub. L. 98–473 substituted ‘‘a public official’’ for
‘‘an officer or employee’’ in first par., and inserted par.
defining ‘‘public official’’.
Statutory Notes and Related Subsidiaries
EFFECTIVE DATE OF 1995 AMENDMENT
Amendment by Pub. L. 104–65 effective Jan. 1, 1996,
except as otherwise provided, see section 24 of Pub. L.
104–65, set out as an Effective Date note under section
1601 of Title 2, The Congress.
EFFECTIVE DATE
Section effective ninety days after July 4, 1966, see
section 9 of Pub. L. 89–486, set out as an Effective Date
of 1966 Amendment note under section 611 of Title 22,
Foreign Relations and Intercourse.
§ 220. Illegal remunerations for referrals to re-
covery homes, clinical treatment facilities,
and laboratories
(a) OFFENSE.—Except as provided in subsection
(b), whoever, with respect to services covered by
a health care benefit program, in or affecting
interstate or foreign commerce, knowingly and
willfully—
(1) solicits or receives any remuneration (in-
cluding any kickback, bribe, or rebate) di-
rectly or indirectly, overtly or covertly, in
Page 85
TITLE 18—CRIMES AND CRIMINAL PROCEDURE
[§ 223
cash or in kind, in return for referring a pa-
tient or patronage to a recovery home, clinical
treatment facility, or laboratory; or
(2) pays or offers any remuneration (includ-
ing any kickback, bribe, or rebate) directly or
indirectly, overtly or covertly, in cash or in
kind—
(A) to induce a referral of an individual to
a recovery home, clinical treatment facility,
or laboratory; or
(B) in exchange for an individual using the
services of that recovery home, clinical
treatment facility, or laboratory,
shall be fined not more than $200,000, imprisoned
not more than 10 years, or both, for each occur-
rence.
(b) APPLICABILITY.—Subsection (a) shall not
apply to—
(1) a discount or other reduction in price ob-
tained by a provider of services or other entity
under a health care benefit program if the re-
duction in price is properly disclosed and ap-
propriately reflected in the costs claimed or
charges made by the provider or entity;
(2) a payment made by an employer to an
employee or independent contractor (who has
a bona fide employment or contractual rela-
tionship with such employer) for employment,
if the employee’s payment is not determined
by or does not vary by—
(A) the number of individuals referred to a
particular recovery home, clinical treatment
facility, or laboratory;
(B) the number of tests or procedures per-
formed; or
(C) the amount billed to or received from,
in part or in whole, the health care benefit
program from the individuals referred to a
particular recovery home, clinical treatment
facility, or laboratory;
(3) a discount in the price of an applicable
drug of a manufacturer that is furnished to an
applicable beneficiary under the Medicare cov-
erage gap discount program under section
1860D–14A(g) of the Social Security Act (42
U.S.C. 1395w–114a(g));
(4) a payment made by a principal to an
agent as compensation for the services of the
agent under a personal services and manage-
ment contract that meets the requirements of
section 1001.952(d) of title 42, Code of Federal
Regulations, as in effect on the date of enact-
ment of this section;
(5) a waiver or discount (as defined in sec-
tion 1001.952(h)(5) of title 42, Code of Federal
Regulations, or any successor regulation) of
any coinsurance or copayment by a health
care benefit program if—
(A) the waiver or discount is not routinely
provided; and
(B) the waiver or discount is provided in
good faith;
(6) a remuneration described in section
1128B(b)(3)(I) of the Social Security Act (42
U.S.C. 1320a–7b(b)(3)(I));
(7) a remuneration made pursuant to an al-
ternative payment model (as defined in sec-
tion 1833(z)(3)(C) of the Social Security Act) or
pursuant to a payment arrangement used by a
State, health insurance issuer, or group health
plan if the Secretary of Health and Human
Services has determined that such arrange-
ment is necessary for care coordination or
value-based care; or
(8) any other payment, remuneration, dis-
count, or reduction as determined by the At-
torney General, in consultation with the Sec-
retary of Health and Human Services, by regu-
lation.
(c) REGULATIONS.—The Attorney General, in
consultation with the Secretary of Health and
Human Services, may promulgate regulations to
clarify the exceptions described in subsection
(b).
(d) PREEMPTION.—
(1) FEDERAL
LAW.—This section shall not
apply to conduct that is prohibited under sec-
tion 1128B of the Social Security Act (42 U.S.C.
1320a–7b).
(2) STATE LAW.—Nothing in this section shall
be construed to occupy the field in which any
provisions of this section operate to the exclu-
sion of State laws on the same subject matter.
(e) DEFINITIONS.—In this section—
(1) the terms ‘‘applicable beneficiary’’ and
‘‘applicable drug’’ have the meanings given
those terms in section 1860D–14A(g) of the So-
cial Security Act (42 U.S.C. 1395w–114a(g));
(2) the term ‘‘clinical treatment facility’’
means a medical setting, other than a hos-
pital, that provides detoxification, risk reduc-
tion, outpatient treatment and care, residen-
tial treatment, or rehabilitation for substance
use, pursuant to licensure or certification
under State law;
(3) the term ‘‘health care benefit program’’
has the meaning given the term in section
24(b);
(4) the term ‘‘laboratory’’ has the meaning
given the term in section 353 of the Public
Health Service Act (42 U.S.C. 263a); and
(5) the term ‘‘recovery home’’ means a
shared living environment that is, or purports
to be, free from alcohol and illicit drug use
and centered on peer support and connection
to services that promote sustained recovery
from substance use disorders.
(Added Pub. L. 115–271, title VIII, § 8122(a), Oct.
24, 2018, 132 Stat. 4108.)
Editorial Notes
REFERENCES IN TEXT
The date of enactment of this section, referred to in
subsec. (b)(4), is the date of enactment of Pub. L.
115–271, which was approved Oct. 24, 2018.
Section 1833(z)(3)(C) of the Social Security Act, re-
ferred to in subsec. (b)(7), is classified to section
1395l(z)(3)(C) of Title 42, The Public Health and Welfare.
PRIOR PROVISIONS
A prior section 220 was renumbered section 215.
[§§ 221, 222. Renumbered §§ 216, 217]
[§ 223. Repealed. Pub. L. 87–849, § 1(c), Oct. 23,
1962, 76 Stat. 1125]
Section, act June 25, 1948, ch. 645, 62 Stat. 696, related
to transactions of the Home Owners’ Loan Corporation.
Cross-references
Connections may be documented source relationships, shared citations or nearby passages. Each explains its basis; a connection alone does not establish applicability to your situation.
Federal law — U.S. Code and appendices · legal_authorities
**(a) Offense.—** Except as provided in subsection (b), whoever, with respect to services covered by a health care benefit program, in or affecting interstate or foreign commerce, knowingly and willfully—
(1) solicits or receives any remuneration (including any kickback, bribe, or rebate) directly or indirectly, overtly or covertly, in cash or in kind, in return for referring a patient or patronage to a recovery home, clinical treatment facility, or laboratory; or
(2) pays or offers any remuneration (including any kickback, bribe, or rebate) directly or indirectly, overtly or covertly, in cash or in kind—
(A) to induce a referral of an individual to a recovery home, clinical treatment facility, or laboratory; or
(B) in exchange for an individual using the services of that recovery home, clinical treatment facility, or laboratory,
shall be fined not more than $200,000, imprisoned not more than 10 years, or both, for each occurrence.
**(b) Applicability.—** Subsection (a) shall not apply to—
(1) a discount or other reduction in price obtained by a provider of services or other entity under a health care benefit program if the reduction in price is properly disclosed and appropriately reflected in the costs claimed or charges made by the provider or entity;
(2) a payment made by an employer to an employee or independent contractor (who has a bona fide employment or contractual relationship with such employer) for employment, if the employee’s payment is not determined by or does not vary by—
(A) the number of individuals referred to a particular recovery home, clinical treatment facility, or laboratory;
(B) the number of tests or procedures performed; or
(C) the amount billed to or received from, in part or in whole, the health care benefit program from
Source: Supplied U.S. Code snapshot — release unconfirmed · 18 U.S.C. § 220
Stored review status: release_metadata_unconfirmed. Same stored citation; legal effect and authority still require review.
Federal law — U.S. Code and appendices · legal_authorities
**(a) Establishment; criteria for regulations; requirements for hospitals** For the purposes of reporting the cost of services provided by, of planning, and of measuring and comparing the efficiency of and effective use of services in, hospitals, skilled nursing facilities, intermediate care facilities, home health agencies, health maintenance organizations, and other types of health services facilities and organizations to which payment may be made under this chapter, the Secretary shall establish by regulation, for each such type of health services facility or organization, a uniform system for the reporting by a facility or organization of that type of the following information:
(1) The aggregate cost of operation and the aggregate volume of services.
(2) The costs and volume of services for various functional accounts and subaccounts.
(3) Rates, by category of patient and class of purchaser.
(4) Capital assets, as defined by the Secretary, including (as appropriate) capital funds, debt service, lease agreements used in lieu of capital funds, and the value of land, facilities, and equipment.
(5) Discharge and bill data.
The uniform reporting system for a type of health services facility or organization shall provide for appropriate variation in the application of the system to different classes of facilities or organizations within that type and shall be established, to the extent practicable, consistent with the cooperative system for producing comparable and uniform health information and statistics described in [section 242k(e)(1) of this title](https://uscode.house.gov/view.xhtml?req=granuleid:USC-prelim-title42-section242k/e/1&num=0&edition=prelim). In reporting under such a system, hospitals shall employ such chart of accounts, definitions, principles, and
Source: Supplied U.S. Code snapshot — release unconfirmed · 42 U.S.C. § 1320a
Stored review status: release_metadata_unconfirmed. The source passage cites 42 U.S.C. § 1320a. This identifies an authority to review, not proof of applicability.
Federal law — U.S. Code and appendices · legal_authorities
Page 2598
TITLE 42—THE PUBLIC HEALTH AND WELFARE
§ 1320
chapter has made a finding (prior to making
such expenditure) that (A) such home is so de-
fective that continued occupancy is unwar-
ranted, (B) unless repairs are made to such
home, rental quarters will be necessary for
such individual, and (C) the cost of rental
quarters to take care of the needs of such indi-
vidual (including his spouse living with him in
such home and any other individual whose
needs were taken into account in determining
the need of such individual) would exceed
(over such time as the Secretary may specify)
the cost of repairs needed to make such home
habitable together with other costs attrib-
utable to continued occupancy of such home,
and
(2) no such expenditures were made for re-
pairing such home pursuant to any prior find-
ing under this section,
the amount paid to any such State for any quar-
ter under section 303(a), 1203(a), 1353(a), or
1383(a) of this title shall be increased by 50 per
centum of such expenditures, except that the ex-
cess above $500 expended with respect to any one
home shall not be included in determining such
expenditures.
(Aug. 14, 1935, ch. 531, title XI, § 1119, as added
Pub. L. 90–248, title II, § 209(a), Jan. 2, 1968, 81
Stat. 894; amended Pub. L. 104–193, title I,
§ 108(g)(5), Aug. 22, 1996, 110 Stat. 2168.)
Editorial Notes
REFERENCES IN TEXT
Section 1383(a) of this title, referred to in text, is a
reference to section 1383(a) of this title as it existed
prior to the general revision of this subchapter by Pub.
L. 92–603, title III, § 301, Oct. 30, 1972, 86 Stat. 1465, eff.
Jan. 1, 1974. The prior section (which is set out as a
note under section 1383 of this title) continues in effect
for Puerto Rico, Guam, and the Virgin Islands
Source: Supplied 2024 U.S. Code historical extraction · 42 U.S.C. § 1320a
Stored review status: historical_2024_not_currentness_verified. The source passage cites 42 U.S.C. § 1320a. This identifies an authority to review, not proof of applicability.
Federal law — U.S. Code and appendices · legal_authorities
**(a) Amounts** Except as provided in [section 1395mm of this title](https://uscode.house.gov/view.xhtml?req=granuleid:USC-prelim-title42-section1395mm&num=0&edition=prelim), and subject to the succeeding provisions of this section, there shall be paid from the Federal Supplementary Medical Insurance Trust Fund, in the case of each individual who is covered under the insurance program established by this part and incurs expenses for services with respect to which benefits are payable under this part, amounts equal to—
(1) in the case of services described in [section 1395k(a)(1) of this title](https://uscode.house.gov/view.xhtml?req=granuleid:USC-prelim-title42-section1395k/a/1&num=0&edition=prelim)—80 percent of the reasonable charges for the services; except that (A) an organization which provides medical and other health services (or arranges for their availability) on a prepayment basis (and either is sponsored by a union or employer, or does not provide, or arrange for the provision of, any inpatient hospital services) may elect to be paid 80 percent of the reasonable cost of services for which payment may be made under this part on behalf of individuals enrolled in such organization in lieu of 80 percent of the reasonable charges for such services if the organization undertakes to charge such individuals no more than 20 percent of such reasonable cost plus any amounts payable by them as a result of subsection (b), (B) with respect to items and services described in [section 1395x(s)(10)(A) of this title](https://uscode.house.gov/view.xhtml?req=granuleid:USC-prelim-title42-section1395x/s/10/A&num=0&edition=prelim), the amounts paid shall be 100 percent of the reasonable charges for such items and services, (C) with respect to expenses incurred for those physicians
Source: Supplied U.S. Code snapshot — release unconfirmed · 42 U.S.C. § 1395w
Stored review status: release_metadata_unconfirmed. The source passage cites 42 U.S.C. § 1395w. This identifies an authority to review, not proof of applicability.
Federal law — U.S. Code and appendices · legal_authorities
Page 3243
TITLE 42—THE PUBLIC HEALTH AND WELFARE
§ 1395w
1 See References in Text note below.
mentary medical insurance program established under
part B of title XVIII of the Social Security Act [42
U.S.C. 1395 et seq.], and (2) provisions will be made for
payment of the monthly premiums of such individuals
for such program.’’
§ 1395w. Appropriations to cover Government
contributions and contingency reserve
(a) In general
There are authorized to be appropriated from
time to time, out of any moneys in the Treasury
not otherwise appropriated, to the Federal Sup-
plementary Medical Insurance Trust Fund—
(1)(A) a Government contribution equal to
the aggregate premiums payable for a month
for enrollees age 65 and over under this part
and deposited in the Trust Fund, multiplied by
the ratio of—
(i) twice the dollar amount of the actuari-
ally adequate rate per enrollee age 65 and
over as determined under section 1395r(a)(1)
of this title for such month minus the dollar
amount of the premium per enrollee for such
month,
as
determined
under
section
1395r(a)(3) of this title, to
(ii) the dollar amount of the premium per
enrollee for such month, plus
(B) a Government contribution equal to the
aggregate premiums payable for a month for
enrollees under age 65 under this part and de-
posited in the Trust Fund, multiplied by the
ratio of—
(i) twice the dollar amount of the actuari-
ally adequate rate per enrollee under age 65
as determined under section 1395r(a)(4) of
this title for such month minus the dollar
amount of the premium per enrollee for such
month,
as
determined
under
section
1395r(a)(3) of this title, to
(ii) the dollar amount of the premium per
enrollee for such month; minus
(C) the aggregate amount of additional pre-
mium payment
Source: Supplied 2024 U.S. Code historical extraction · 42 U.S.C. § 1395w
Stored review status: historical_2024_not_currentness_verified. The source passage cites 42 U.S.C. § 1395w. This identifies an authority to review, not proof of applicability.
Federal law — U.S. Code and appendices · legal_authorities
**(a) “Laboratory” or “clinical laboratory” defined** As used in this section, the term “laboratory” or “clinical laboratory” means a facility for the biological, microbiological, serological, chemical, immuno-hematological, hematological, biophysical, cytological, pathological, or other examination of materials derived from the human body for the purpose of providing information for the diagnosis, prevention, or treatment of any disease or impairment of, or the assessment of the health of, human beings.
**(b) Certificate requirement** No person may solicit or accept materials derived from the human body for laboratory examination or other procedure unless there is in effect for the laboratory a certificate issued by the Secretary under this section applicable to the category of examinations or procedures which includes such examination or procedure.
**(c) Issuance and renewal of certificates**
(1) **In general** — The Secretary may issue or renew a certificate for a laboratory only if the laboratory meets the requirements of subsection (d).
(2) **Term** — A certificate issued under this section shall be valid for a period of 2 years or such shorter period as the Secretary may establish.
**(d) Requirements for certificates**
(1) **In general** — A laboratory may be issued a certificate or have its certificate renewed if—
(A) the laboratory submits (or if the laboratory is accredited under subsection (e), the accreditation body which accredited the laboratory submits), an application—
(i) in such form and manner as the Secretary shall prescribe,
(ii) that describes the characteristics of the laboratory examinations and other procedures performed by the laboratory including—
(I) the number and types of laboratory examinations and other procedures
Source: Supplied U.S. Code snapshot — release unconfirmed · 42 U.S.C. § 263a
Stored review status: release_metadata_unconfirmed. The source passage cites 42 U.S.C. § 263a. This identifies an authority to review, not proof of applicability.
Federal law — U.S. Code and appendices · legal_authorities
Page 477
TITLE 42—THE PUBLIC HEALTH AND WELFARE
§ 263a
(B) information related to development
programs for biological products, including
biosimilar biological products and inter-
changeable biosimilar biological products
and relevant clinical considerations for pre-
scribers, which may include, as appropriate
and applicable, information related to the
comparability of such biological products;
(C) an explanation of the process for re-
porting adverse events for biological prod-
ucts, including biosimilar biological prod-
ucts and interchangeable biosimilar biologi-
cal products; and
(D) an explanation of the relationship be-
tween biosimilar biological products and
interchangeable biosimilar biological prod-
ucts licensed under section 262(k) of this
title and reference products (as defined in
section 262(i) of this title), including the
standards for review and licensing of each
such type of biological product.
(3) Format
The educational materials provided under
paragraph (1) may be—
(A) in formats such as webinars, con-
tinuing education modules, videos, fact
sheets, infographics, stakeholder toolkits, or
other formats as appropriate and applicable;
and
(B) tailored for the unique needs of health
care providers, patients, caregivers, and
other audiences, as the Secretary deter-
mines appropriate.
(4) Other information
In addition to the information described in
paragraph (2), the Secretary shall continue to
publish—
(A) the action package of each biological
product licensed under subsection (a) or (k)
of section 262 of this title; or
(B) the summary review of each biological
product licensed under subsection (a) or (k)
of section 262 of this title.
(5) Confidential and trade secret information
This subsection does not authorize the di
Source: Supplied 2024 U.S. Code historical extraction · 42 U.S.C. § 263a
Stored review status: historical_2024_not_currentness_verified. The source passage cites 42 U.S.C. § 263a. This identifies an authority to review, not proof of applicability.